Credit Agricole
OCUL icon

Credit Agricole’s Ocular Therapeutix OCUL Stock Holding History

Credit Agricole’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$81.4K Hold
11,100
– – ﹤0.01% 1142
2024
Q4 		$94.8K Hold
11,100
– – ﹤0.01% 1159
2024
Q3 		$96.6K Buy
+11,100
New +$91.5K ﹤0.01% 1116

Other funds holding OCUL

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Agricole's OCUL Position: Q1 2025 in Review

Credit Agricole held its Ocular Therapeutix (OCUL) position steady in Q1 2025 at 11,100 shares worth $81.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Credit Agricole first reported a position in OCUL in Q3 2024 and has held it in 3 quarters since. The position peaked at $96.6K in Q3 2024. 196 funds tracked by Wall St. Rank hold OCUL as of Q1 2025.

  • Credit Agricole held 11,100 shares of Ocular Therapeutix worth $81.4K as of Q1 2025.
  • Credit Agricole left its Ocular Therapeutix share count unchanged in Q1 2025.
  • Ocular Therapeutix made up ﹤0.01% of Credit Agricole's portfolio in Q1 2025, its #1142 holding.
  • Credit Agricole first reported a position in Ocular Therapeutix in Q3 2024 and has held it in 3 quarters since.
  • Credit Agricole's Ocular Therapeutix position peaked at $96.6K in Q3 2024.
  • 196 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2025.

Based on Credit Agricole's 13F filing for Q1 2025, filed 14 May 2025.